Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double‐Blind, Randomised, Phase 3 Trial ( ReSTORE China)

Documenti analoghi

• Cost‐Effectiveness of Once Weekly Rezafungin for the Treatment of Invasive Candidiasis in the United Kingdom
  di: Noemi Muszbek, et al.
  Pubblicazione: (2026)
• The In Vitro Activity of Rezafungin Against Uncommon Species of Candida
  di: Marisa L. Winkler, et al.
  Pubblicazione: (2024)
• Physician's Compliance to Clinical Practice Guidelines and Outcomes of Patients With Invasive Candidiasis in a University Hospital in Thailand
  di: Nantaporn Pirogard, et al.
  Pubblicazione: (2025)
• Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial
  di: Sara García‐Oreja, et al.
  Pubblicazione: (2025)
• T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis
  di: Yawen Xie, et al.
  Pubblicazione: (2025)